Tooth extraction in patients on zoledronic acid therapy

Oral Oncology

Volumn 48, Issue 9, 2012, Pages 817-821

  Mozzati, Marco ^a   Arata, Valentina ^a   Gallesio, Giorgia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Acid zoledronic; Bisphosphonates; Bone healing; BRONJ; PRGF; Socket healing; Tooth extraction; Wound healing

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ERYTHROMYCIN; GROWTH FACTOR; PLASMA RICH IN GROWTH FACTOR; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; JAW OSTEONECROSIS; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OSTEOBLAST; OSTEOCLAST; PANORAMIC RADIOGRAPHY; PLASMA; PRIORITY JOURNAL; TOOTH EXTRACTION; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; DIPHOSPHONATES; HUMANS; IMIDAZOLES; JAW DISEASES; OSTEONECROSIS; RADIOGRAPHY, PANORAMIC; TOMOGRAPHY, X-RAY COMPUTED; TOOTH EXTRACTION;

EID: 84865193687     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.03.009     Document Type: Article

References (36)

1. C.A. Migliorati, M.A. Siegel, and L.S. Elting Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment Lancet Oncol 7 2006 508 514 (Pubitemid 43779167)
2. C.A. Migliorati Bisphosphanates and oral cavity avascular bone necrosis J Clin Oncol 21 2003 4253 4254
3. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117 (Pubitemid 37064711)
4. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534 (Pubitemid 38542516)
5. R.E. Marx, Y. Sawatari, M. Fortin, and V. Broumand Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567 1575 (Pubitemid 41525412)
6. P.F. Conte, P.G. Giannessi, J. Latreille, L. Mauriac, L. Koliren, and F. Calabresi Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial Ann Oncol 5 Suppl 7 1994 S41
7. S. Rayman, K. Almas, and E. Dincer Bisphosphonate-related jaw necrosis: a team approach management and prevention Int J Dent Hyg 7 2009 90 95
8. M. Bezzi, M. Hasmim, G. Bieler, O. Dormond, and C. Ruegg Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt J Biol Chem 278 2003 43603 43614 (Pubitemid 37345986)
9. Y. Hamma-Kourbali, M. Di Benedetto, D. Ledoux, O. Oudar, Y. Leroux, and M. Lecouvey A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis Biochem Biophys Res Commun 310 2003 816 823 (Pubitemid 37188695)
10. J. Wood, K. Bonjean, S. Ruetz, A. Bellahcene, L. Devy, and J.M. Foidart Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid J Pharmacol Exp Ther 302 2002 1055 1061 (Pubitemid 34920226)
11. P. Fournier, S. Boissier, S. Filleur, J. Guglielmi, F. Cabon, and M. Colombel Bisphosphonates inhibit angiogenesis in vitro and testosterone- stimulated vascular regrowth in the ventral prostate in castrated rats Cancer Res 62 2002 6538 6544 (Pubitemid 35364119)
12. I.R. Reid, M.J. Bolland, and A.B. Grey Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41 2007 318 320 (Pubitemid 47199147)
13. I.M. Twiss, R. de Water, J. den Hartigh, R. Sparidans, W. Ramp-Koopmanschap, and H. Brill Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport J Pharm Sci 83 1994 699 703 (Pubitemid 24219823)
14. I.M. Twiss, O. Pas, W. Ramp-Koopmanschap, J. Den Hartigh, and P. Vermeij The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium J Bone Miner Res 14 1999 784 791 (Pubitemid 29210605)
15. R. Landesberg, M. Cozin, S. Cremers, V. Woo, S. Kousteni, and S. Sinha Inhibition of oral mucosal cell wound healing by bisphosphonates J Oral Maxillofac Surg 66 2008 839 847 (Pubitemid 351522817)
16. Scoletta M, Arduino PG, Reggio L, Dalmasso P, Mozzati M. Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study. Photomed Laser Surg 28: 179-84.
17. T. Van den Wyngaert, M.T. Huizing, and J.B. Vermorken Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy? Ann Oncol 17 2006 1197 1204 (Pubitemid 44288209)
18. S.B. Woo, J.W. Hellstein, and J.R. Kalmar Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws Ann Intern Med 144 2006 753 761 (Pubitemid 46780635)
19. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65: 369-76.
20. E. Anitua, M. Sanchez, M.M. Zalduendo, M. de la Fuente, R. Prado, and G. Orive Fibroblastic response to treatment with different preparations rich in growth factors Cell Prolif 42 2009 162 170
21. R. Marx, and A. Garg Dental and craniofacial applications of platelet-rich plasma 2005 Quintessence Publishing Chicago
22. D. Santini, B. Vincenzi, G. Dicuonzo, G. Avvisati, C. Massacesi, and F. Battistoni Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients Clin Cancer Res 9 2003 2893 2897 (Pubitemid 36993246)
23. E. Anitua, G. Orive, R. Pla, P. Roman, V. Serrano, and I. Andia The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: a histologic and histomorphometric study J Biomed Mater Res A 91 2009 158 165
24. S.D. Bianchi, M. Scoletta, F.B. Cassione, G. Migliaretti, and M. Mozzati Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 2007 249 258
25. A. Brotons, and M. Penarrocha Orofacial neurogenic pain and maxillofacial ischemic osteonecrosis. A review Med Oral 8 2003 157 165 (Pubitemid 36628552)
26. R. Marx Oral & intravenous bisphosphonate. Induced osteonecrosis of the jaws Q.P. Co, Half-day Seminar 2007 Quintessence Publishing Co. Hanover Park, Illinois
27. C.I. Ripamonti, M. Maniezzo, T. Campa, E. Fagnoni, C. Brunelli, and G. Saibene Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan Ann Oncol 20 2009 137 145
28. G. Lodi, A. Sardella, A. Salis, F. Demarosi, M. Tarozzi, and A. Carrassi Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series J Oral Maxillofac Surg 68 2010 107 110
29. S.L. Ruggiero, and B. Mehrotra Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management Ann Rev Med 60 2009 85 96
30. Y. Kobayashi, T. Hiraga, A. Ueda, L. Wang, M. Matsumoto-Nakano, and K. Hata Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice J Bone Miner Metab 28 2010 165 175
31. Scoletta M, Arduino PG, Dalmasso P, Broccoletti R, Mozzati M. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: A prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
32. H. Hikita, K. Miyazawa, M. Tabuchi, M. Kimura, and S. Goto Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats J Bone Miner Metab 27 2009 663 672
33. E. Anitua Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants Int J Oral Maxillofac Implants 14 1999 529 535
34. J.L. Rutkowski, J.W. Fennell, J.C. Kern, D.E. Madison, and D.A. Johnson Inhibition of alveolar osteitis in mandibular tooth extraction sites using platelet-rich plasma J Oral Implantol 33 2007 116 121
35. Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol 2012.
36. M. Mozzati, V. Arata, G. Gallesio, and S. Carossa A dental extraction protocol with plasma rich in growth factors (PRGF) in patients on intravenous bisphosphonate therapy: a case-control study Joint Bone Spine 78 6 2011 648 649